chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Provider now has a red and itchy right eye.; Priming an MMRII vaccine a small amount may have gotten in her right eye.; This spontaneous report has been received from a nurse practitioner referring to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported.      On 26-OCT-2022, when the patient was priming a measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (lot number U013035 had been verified to be a valid number; expiration date 23-APR-2023, and upon internal validation established as the same date), for prophylaxis (dose, vaccination scheme, frequency, route of administration, anatomical site of injection were not reported) vaccine, a small amount may have gotten in her right eye (exposure via eye contact). It was reported that the event "occurred at approximately 14:40 Eastern Time. The patient now has a red and itchy right eye (ocular hyperaemia). She has experienced no vison changes or blurring at this time." The outcome of ocular hyperaemia was not provided.     The causality assessment between measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) and the event ocular hyperaemia was not provided.
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 17-JUN-2019, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number R029815 with expiration date in 18-JUN-2020) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001849: US-009507513-1906USA011434: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA001847: US-009507513-1907USA000952: US-009507513-1907USA000989: US-009507513-1907USA000962: US-009507513-1907USA000988: US-009507513-1907USA000963: US-009507513-1907USA000959: US-009507513-1907USA000968: US-009507513-1907USA000967: US-009507513-1907USA000964: US-009507513-1907USA000966: US-009507513-1907USA000954: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000965:
patient's arm became very red, inflammed and warm to the touched. called in again on 9/19/2023 to alert us that pain had radiated up to her neck
Approx 15 minutes after the injection the client complianed of nasal stuffiness and feeling like her throat was closing. The nurse administered Epinepherine 0.5ml and symptoms abated.  Her vital signs remained stable throughout.
8-17-20: sore throat 8-18-20: sore muscles (thigh, buttox, hips, calves, lower back).  Progressed to seveRe pain for 4 weeks; also Chills. Insomnia due to pain - 4+ weeks; also severe muscle weakness. Pain felt like P.M.R pain experienced 11 yrs ago from Lipitor Rxed mega dose (80mg) Muscle pain & weakness still present (11-5-20) muscle pain & weakness (Lower body) still present but improving with time, Rest, and physical therapy. I was in great physical shape until flu vaccination - swam 50 laps per day, walked 1.6 miles 3x/week, worked out 2/week, at a gym, and have 26 flower beds that I maintain. Something very serious happened to me, and its not over! Please Cross reference: (A) High Dose influenza vaccine with history of Polymyalgia Rheumatica. (B) High Dose influenza vaccine with history of BCG infusion of T.B (tuberculin) immunotherapy treatment for transitional cell carcinoma (early stage) of the Bladder. (C) High dose influenza vaccine with Bladder Cancer. I would appreciate a reply.
nausea; fever; tiredness; This case was reported by a consumer via (Shingrix GSK Chatbot) interactive digital media and described the occurrence of nausea in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced nausea, fever and tiredness. On an unknown date, the outcome of the nausea, fever and tiredness were unknown.   It was unknown if the reporter considered the nausea, fever and tiredness to be related to Shingrix.   Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient experiencing fever, tiredness nausea. The reporter asked how long could he/she expect adverse reactions to Shingrix 2 vaccine to last. No contact details were reported.
per patient: "On 5/26/21 received the 2nd dose of Moderna Vaccine. Around noon experienced headache, left earche and tingling to left foot. Around 1pm started having trouble breathing and later that evening felt like someone was standing on my chest. Took Excedrin EC for headaches. Headache lasted for a day or two. Felt like i was forcing myself to breathe instead of coming naturally".
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EL9261), in right arm for covid-19 immunization. The patient's relevant medical history included: "Pancreatic cancer" (unspecified if ongoing); "Shellfish" (unspecified if ongoing). Concomitant medication(s) included: CALCIUM; VIT D3; ASPIRIN [ACETYLSALICYLIC ACID]; PANTOPRAZOLE. The following information was reported: HYPOAESTHESIA (non-serious) with onset Mar2021, outcome "not recovered", described as "Peripheral numbness feet, legs"; PARAESTHESIA (non-serious) with onset Mar2021, outcome "not recovered", described as "tingling in hands". The events "peripheral numbness feet, legs" and "tingling in hands" required physician office visit. Therapeutic measures were taken as a result of hypoesthesia, paranesthesia.
bilateral paplliodema and idiopathic increased intracranial pressure; This is a spontaneous report from a contactable consumer (nurse). A 33-year-old female patient received BNT162B2, via an unspecified route of administration, administered in the left arm on 10Feb2021 (Lot Number: EL3247) as unknown, single for COVID-19 immunization. Medical history included depression and Polycystic ovarian syndrome (PCOS), both from an unknown date and unknown if ongoing. No known allergies. Concomitant medications included ziprasidone hydrochloride (GEODON [ZIPRASIDONE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; ethinylestradiol, norgestimate (SPRINTEC) taken for an unspecified indication, start and stop date were not reported. On 08Apr2021 12:00, the patient experienced bilateral paplliodema and idiopathic increased intracranial pressure. Therapeutic measures were taken as a result of bilateral paplliodema and idiopathic increased intracranial pressure which included lumbar puncture and acetazolamide. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The adverse event result in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The outcome of the event was not recovered.
pt recvd vax & exp sensation of jaw locking when talking; mostly on lt side; it locks the jaw & prevents pt from closing her mouth; In hosp was told had allerg rxn to MMR:
Redness, swelling, itching on feet, ankles, up to knee, fever, chill.
This case was reported by a healthcare professional and described the occurrence of low hepatitis B antibody level in an adult female subject who was vaccinated with TWINRIX, GlaxoSmithKline.  In 2005 the subject received 1st and 2nd dose of TWINRIX at 1.0 ml.  At an unspecified time after the 2nd vaccination with TWINRIX, the subject was tested and did not show protection against hepatitis A and hepatitis B.  It was reported that the subject was not found to have protective levels for either hepatitis A or B (low hepatitis A antibody level and low hepatitis B antibody level).  At the time of reporting the outcome of the events was unspecified.
LT Arm Pain and swelling of arm and Lt hand  , treated with hot and cold packs and pain relievers, still have pain and swelling 5 weeks after shot
Extreme shortness of breath, fatigue, exercise intolerance, unable to work, unable to do much besides rest, dizziness, right sided numbness,
PATIENT CALLED IN AND REPORTED WELPS ON BOTH LEGS AND ARMS WITH SHORTNESS OF BREATH AND TACHYCARDIA.  PATIENT STATES SYMPTOMS PRESNTED 1 DAY AFTER VACCINATION.  PATIENT WAS ADVISED TO VISIT NEAREST EMERGENCY ROOM AS SOON AS POSSIBLE.
2 days of migraine, joint and muscle pain throughout body, low-grade fever, fatigue/drowsiness
I have been getting constant Blisters in my mouth. Very noticeable when I eat spicy food or lemon or chocolate. They last 2 to 3 days...go away 2 to 3 days...then return.
After the vaccine, the left arm was sore, whole body felt fatigue, and slight back ache. Took tylenol 2-times a day for 2 days. After about a week from getting the vaccine, left was itchy at the vaccine site and coin sized red rash developed. At first I did not relate it as a reaction to the vaccine. But as the rash got little bigger I took zyrtec on 1/16/2021 & 1/18/2021 and benadryl on 1/19/2021 & 1/20/2021. Now the redness/ rash seems to have spread. It looks like a red oval outline (no redness in the center), size of the palm, and the site feels slightly warm to touch.
After receiving first dose of vaccine, within eight hours, I was experiencing 1/10 intermittent chest tightness. I had no other symptoms (I was not anxious or experiencing anxiety). These symptoms resolved on there own within 24 hours.   After receiving the 2nd dose of Pfizer, I only had mild aches and fatigue within the first 24 hours. The next day while I was getting a hair cut, I had an episode of syncope where I almost passed out while sitting in the chair. I immediately went over to the couch to lay down before I blacked out.  After 48 hours of receiving the 2nd dose of vaccine, I developed severe 6/10 chest pain which felt like a vise grip around my heart after having sexual intercourse. This only lasted 5 seconds and then came back again only lasting a few more seconds. I never had any further episodes since.  After 36 hours of receiving the 2nd vaccine, I had tenderness on the LEFT lateral border of my chest. I noticed there was what appeared to be a red inflamed lymph node about the size of a quarter. This was very sore, and I was unable to sleep on this side.  I spoke with the family doctor who confirmed this appears to be a swollen lymph node and recommended I take a baby aspirin twice a day.
Patient states adverse reaction began approximately 2 weeks after vaccine. Initially began with soreness at the site and pain under her arm.  The soreness at the site resolved and the pain under her arm travelled to her L breast. She says the pain is not unbearable but it is causing concern. There is less pain when wearing undergarment.
Following the COVID-19 Pfizer vaccine, I noticed the dent in my left shoulder at the injection site, which has become significantly larger and appears to be muscular atrophy. I have been advised that the skin and fat at the site have died in that caused the dented region.
This case was reported by a mother of a consumer and described the occurrence of injection site soreness in a 8-year-old female subject who was vaccinated with FLULAVAL. A physician or other health care professional has not verified this report. There were no concurrent medications. On 8 October 2008 the subject received unspecified dose of FLULAVAL at 0.5 ml. On 8 October 2008, less than one day after vaccination with FLULAVAL, the subject experienced injection site soreness. Administration of FLULAVAL to this subject was considered to be a drug administration error as FLULAVAL is not indicated for use in subjects under the age of 18 years. At the time of reporting, injection site soreness was resolved. Follow-up via the mother indicated that the subject has experienced no other side effects.
Pregnant patient received fluzone QV vaccine with no reported adverse event; Initial information received on 14-Sep-2022 regarding an unsolicited valid non-serious case received from health professional.  This case involves a 32-year-old female patient who was exposed to vaccine Influenza Quadrival A-B Vaccine [Fluzone QIV] in context of pregnant patient received fluzone qv vaccine with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e., before pregnancy outcome was known. The reported Pregnant patient received fluzone QV vaccine with no reported adverse event occurred at 37 weeks of pregnancy and during pregnancy trimester.   The date of last menstrual period was reported as 27-Dec-2021. The estimated due date is 03-Oct-2022. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was unknown if patient had previous pregnancy.    On 14-Sep-2022, the pregnant patient received of suspect Fluzone QIV Suspension for injection at dose 1 DF (dosage form) via intramuscular route in the left deltoid (lot: UT7682KA) for prophylactic vaccination with no reported adverse event (exposure during pregnancy) at same day latency.  Action taken: Not applicable.  At time of reporting, the outcome was Unknown for the event exposure during pregnancy. Additionally, at time of reporting, the pregnancy is still ongoing.
Fever (102 degrees F), chills started Friday at 9am Took Tylenol 500mg  at 5 am (for the arm pain) and 9:30 am  (for fever) on Friday. The fever lasted until about 1am on Saturday.
Information has been received from a certified medical assistant referring to an unspecified number of patients of unknown age and gender. Patients' pertinent medical history and concurrent condition were not reported. ON an unknown date the unspecified number of patients received improperly stored GARDASIL (dose, frequency and route were unknown, lot # K011562, expiration date 8-APR-2017). No concomitant medication was reported. No adverse effects reported. There was no product quality complaints (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
labs are abnormal; blood pressure dropping; Then 8 days later i developed throbbing pain head to toe; low grade temp; sweats; swelling of joints, especially my fingers, hands and feet; swelling of joints, especially my fingers, hands and feet; diarrhea; dizziness; problems thinking; anxiety; About 4 hours after receiving my Covid vaccine I started to feel fatigue/severe fatigue; This is a spontaneous report from a contactable Nurse (Patient). A 43-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular, administered in Arm Right on 08Apr2021 16:00 (Batch/Lot Number: EK8734) at the age of 43-years-old as single dose for covid-19 immunisation. The COVID-19 vaccine was administered at Pharmacy or Drug Store. Patient was not pregnant. Medical history included Rheumatoid Arthritis, fibromyalgia, anxiety/depression, Known allergies: Sulfa, Covid-19 prior vaccination. Post the vaccination, the patient was not been tested for COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported; duloxetine hydrochloride (CYMBALTA) taken for an unspecified indication, start and stop date were not reported; lorazepam (ATIVAN) taken for an unspecified indication, start and stop date were not reported. About 4 hours on 08Apr2021 after receiving her Covid vaccine she started to feel fatigue. Then 8 days later on 16Apr2021 08:00 AM, patient developed throbbing pain from head to toe, severe fatigue, low grade temp, sweats, swelling of joints, especially her fingers, hands and feet, diarrhea, blood pressure dropping, dizziness, problems thinking, and anxiety. His symptoms have progressively gotten worse and she had seen her family doctor, and her rheumatologist. Events resulted in: Doctor or other healthcare professional office/clinic visit. Leflunomide (ARAVA) and ibuprofen (MOTRIN) to help with inflammation and swelling. Her labs were abnormal, but chest X-ray normal on an unknown date. She have been off work since 26Apr2021. The outcome of the events was not recovered.
Information has been received from a Licensed Practical Nurse (LVN) referring to a patient of unknown age and gender. There was no medical history or concurrent condition reported. On 19-AUG-2015 the patient was vaccinated with a dose of expired M-M- R II (lot # J006140, expiry date 17-APR-2015) (dosage, strength and route were not reported). There was no concomitant medication reported. At the time of the report, no symptoms was reported. This is one of several reports received from the same reporter. Additional information has been requested.
other zoster related injuries; shingles; Initial information has been received from a lawyer, regarding a case in litigation, and refers to a patient (pt) of unknown gender who at the time of vaccination with zoster vaccine live (ZOSTAVAX) was 65 years old. No information was provided about the pt's medical history, concurrent conditions or concomitant medications. On or about 01-OCT-2013, the pt was administered zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) by a healthcare provider at a clinic for the long-term prevention of shingles and zoster-related conditions. Subsequently, on unknown dates, the pt was treated by a physician at a clinic, and other healthcare providers, for the following injuries resulting from the pt's zoster vaccine live (ZOSTAVAX): shingles and other zoster related injuries. The outcome of the events was not provided. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
p/vax devel shaking; chills; fever & nausea x3 days;
This spontaneous case reported by a consumer, describes the occurrence of myalgia (sore arm first day improvement second day) in a 98-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced myalgia (sore arm first day improvement second day). At the time of the report, myalgia (sore arm first day improvement second day) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information provided. This case linked to MOD-2021-262532 (patient link). Most recent follow-up information incorporated: On Jul 29, 2021: Significant follow-up appended. Patient's initials and age updated.
10/10 - Pneumonia and Flu administered 10/17 - Called HD said rt arm numb, instructed her to go to see PMD
I flew abroad on or about 9/15/2022 or 9/16/2022, I flew abroad; during the flight, I noticed that someone two rows ahead of me was coughing. I felt fine on 9/29/2022. I was vacationing abroad when, on 9/30/2022, I was tested negative for COVID-19 in the afternoon. I coughed some that evening, but I didn't give it much thought. I slept fine. On 1/1/2022, I felt fine at first, but somewhere in the afternoon or evening, I began coughing more. At first, it was a very dry cough. On 10/2/2022, I went to a pharmacy and was given some lozenges to help soothe the dryness. I continued to have a very aggressive, uncontrollable cough, though. On 10/3/2022, I continued to have the cough, but it felt like it was deeper in the lungs, and I was coughing up a lot of mucus. I went to another pharmacy as was given an expectorant, which I took. I continued to have a nasty cough and had difficulty sleeping. On 10/6/2022, I felt better. On 10/7/2022, I walked around a lot. On 10/8/2022, my arthritis in both my knees flared up, and I took ADVIL, which helped. On about 10/12/2022, I flew back home. The knee pain continued for the following month. On 11/22/2022, I saw my NP, who gave me steroid or cortisone injections in my knees. My knees returned to normal fairly rapidly, and they felt like they did before the flare-up.
swelling of throat from tonsils down to airway to collar bone, across bottom of chin, from ear to ear, affecting swallowing, breathing and hearing.  took Benadryl every 4 hours. called pharmacy next day, they said to report to doctor. take a prednsone as well. the benadryl only took it down to halfway, the prenisone reduced it significantly. as soon as the benadryl wore off, it began to tighten again. severe gag feeling. contacted doctor to get appointment asap. will take another prednisone if needed.
My upper left arm at the injection site was sore for the first three days, then the soreness was gone and I felt fine. After a week, I discovered tension on the upper left arm. It feels like the swelling persisted after a week and the injection site's skin temperature is also higher than my right arm.  I was using V-safe to report and track my symptoms. However the health check-in stopped Saturday, so I wasn't able to report this discovery.
The evening of 9/22/23 pt developed a severe headache.  She said it felt like a migraine but much worse.  Pain level up to 9/10.  Required a doctor's visit on 9/27 because she is still having the headache.  She does have vertigo also.  The night of the vaccine, she did have body aches and chills.
Within 3 hours of injection:  Fever, 101 degrees x 10 hours; reduced fever fluctuated for 12 hours thereafter severe chills x 2 hours weakness nausea
explosive loose bowel movements with burning anus for two weeks (burning elemenations continue still); head ache on top of head - several days; puffy face;  Brief Chest pain on 4/4/21 with fatigue following for several hours and balance problems. pain in left plantar fascia and discomfort in right Siatic nerve area and upper thigh 4/13 Cough - productive; patient is mostly recovered from adverse reactions with exception of burning bowel movements